Perfluorooctanoic acid induces transcriptomic alterations in second trimester human cytotrophoblasts

Toxicol Sci. 2023 Nov 28;196(2):187-199. doi: 10.1093/toxsci/kfad097.

Abstract

Poly- and perfluroroalkylated substances (PFAS) are a major class of surfactants used in industry applications and consumer products. Despite efforts to reduce the usage of PFAS due to their environmental persistence, compounds such as perfluorooctanoic acid (PFOA) are widely detected in human blood and tissue. Although growing evidence supports that prenatal exposures to PFOA and other PFAS are linked to adverse pregnancy outcomes, the target organs and pathways remain unclear. Recent investigations in mouse and human cell lines suggest that PFAS may impact the placenta and impair trophoblast function. In this study, we investigated the effects of PFOA on cytotoxicity and the transcriptome in cultured second trimester human cytotrophoblasts (CTBs). We show that PFOA significantly reduces viability and induces cell death at 24 h, in a concentration-dependent manner. At subcytotoxic concentrations, PFOA impacted expression of hundreds of genes, including several molecules (CRH, IFIT1, and TNFSF10) linked with lipid metabolism and innate immune response pathways. Furthermore, in silico analyses suggested that regulatory factors such as peroxisome proliferator-activated receptor-mediated pathways may be especially important in response to PFOA. In summary, this study provides evidence that PFOA alters primary human CTB viability and gene pathways that could contribute to placental dysfunction and disease.

Keywords: cytotrophoblast; human; per- and polyfluoroalkyl substances (PFAS); peroxisome proliferator-activated receptor; placenta; transcriptomics.

MeSH terms

  • Alkanesulfonic Acids* / toxicity
  • Animals
  • Female
  • Fluorocarbons*
  • Humans
  • Mice
  • Placenta
  • Pregnancy
  • Pregnancy Trimester, Second
  • Transcriptome
  • Trophoblasts

Substances

  • perfluorooctanoic acid
  • Fluorocarbons
  • Alkanesulfonic Acids